Utilization of Long-Acting Reversible Contraceptives in the United States After vs Before the 2016 US Presidential Election

Lydia E Pace; Stacie B Dusetzina; Mara E Murray Horwitz; Nancy L Keating

doi:10.1001/jamainternmed.2018.7111

Utilization of Long-Acting Reversible Contraceptives in the United States After vs Before the 2016 US Presidential Election

JAMA Intern Med. 2019 Mar 1;179(3):444-446. doi: 10.1001/jamainternmed.2018.7111.

Authors

Lydia E Pace¹, Stacie B Dusetzina², Mara E Murray Horwitz³, Nancy L Keating⁴

Affiliations

¹ Division of Women's Health, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
³ Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
⁴ Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.

Abstract

This study examines the utilization rate of long-acting reversible contraceptives after the 2016 US presidential election compared with before the election and during the same period in 2015.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Contraception Behavior / statistics & numerical data*
Contraceptive Agents, Female / therapeutic use*
Drug Implants
Female
Humans
Intrauterine Devices / statistics & numerical data*
Middle Aged
Politics*
Time Factors
United States

Substances

Contraceptive Agents, Female
Drug Implants